Hemp-powered skincare model Hey Bud has rolled into greater than 400 Priceline shops nationwide, because the startup readies for Australian authorities to embrace a higher number of hashish and CBD-infused merchandise.
Hey Bud presents a variety of serums, cleansers, and clay masks infused with hempseed oil, a pure product touted for its anti-inflammatory properties.
While hemp is derived from the hashish plant household, hempseed oil comprises no psychoactive substances — even when the Hey Bud title does cheekily allude to the plant’s extra well-known cousin.
Officially launched in 2020 by Melbourne co-founders Alex Roslaniec, Ollie Watts, and Fedele D’Amico, Hey Bud instructions its personal webstore and an engaged, youthful fanbase with greater than 210,000 Instagram followers.
Get day by day enterprise information.
The newest tales, funding data, and professional recommendation. Free to enroll.
The firm claims to have made $10 million in gross sales in its transient historical past.
Partnering with Priceline will assist the model attain much more younger clients, Roslaniec says, given the overlap between Hey Bud’s current customers and the pharmacy chain’s core buyer base.
“What we discovered from talking to some completely different retailers was that Priceline’s buyer demographic actually made quite a lot of sense for us,” Roslaniec instructed SmartCompany.
“So quite a lot of our clients do store within the likes of Priceline, and so they even have a really related age demographic as nicely.”
“We know clients have been eager to see our merchandise on store cabinets for some time now, and we’re so excited to lastly make that occur,” co-founder Ollie Watts mentioned in an announcement.
The firm can be exploring worldwide distribution alternatives, Fedele added.
More broadly, the Priceline growth will assist Hey Bud on its mission of “truly educating our clients, and ensuring that we’re breaking down the stigma of hashish as a result of it doesn’t have this psychoactive part to it”.
At the identical time, Hey Bud is retaining a eager eye on the CBD product market.
While docs are free to prescribe pharmaceutical hashish in sure circumstances, entry to cannabis-based merchandise like CBD oil is strictly regulated in Australia.
Given the prevalence of legalised CBD-infused shopper merchandise within the US, Canada, and the UK, Roslaniec says clients are keen to listen to about legislative developments at house.
“What we’re discovering from quite a lot of our clients is that they’re truly asking us, they’re trying to us for solutions when CBD will turn into authorized inside Australia,” he mentioned.
“I consider that it’s solely a matter of time earlier than CBD and hashish turn into extra recreationally legalised right here in Australia which we’re retaining a really shut eye on,” he added.
The firm is “speaking to formulators abroad to grasp what the method seems to be like as nicely in order that we’re able to pivot into that house.”